MV TELEGRAPH DAILY NEWS
Participants of the HIMSS conference walk around the exhibition area Source: HIMSS Debates about artificial intelligence and its role in healthcare were the focus of this week’s HIMSS Global Health Conference in Chicago, which brought together more than 35,000 physicians, other healthcare professionals, executives and engineers to discuss the latest advances in healthcare and technology. …
Continue reading “AI is on the coronary heart of HIMSS to scale back paperwork”
Pictured here is a Novo Nordisk insulin pen on display on March 14, 2023 in Miami, Florida. Joe Raedle | News from Getty Images | Getty Images The top executives of the three drug companies that control 90% of the global insulin market will testify before the Senate Health Committee on May 10 about cutting …
Continue reading “Drug firm CEOs to testify earlier than Senate Well being on insulin worth”
In this image illustration, a Johnson and Johnson baby powder container is on display on April 5, 2023 in San Anselmo, California. Justin Sullivan | Getty Images A federal bankruptcy judge on Thursday halted around 40,000 lawsuits that claimed Johnson&Johnson‘s baby powder and other talc products caused cancer. The decision is part of J&J’s second …
Continue reading “US choose halts discuss most cancers lawsuits in opposition to Johnson & Johnson”
The United States is the only advanced economy that does not guarantee paid time off. “You have entire cultures like France … where pretty much everyone takes August off, and it’s just part of the culture there,” said Shawn Fremstad, director of law and political economy at the Center for Economic and Policy Research. “You …
Continue reading “Why US furlough coverage is a lot worse than Europe’s”
Johnson&Johnson Shares fell on Tuesday after the company reported adjusted earnings and revenue that beat Wall Street expectations but lowered its sales guidance for its pharmaceuticals business. J&J, whose financial results are a guide for many healthcare companies, said its sales for the quarter rose 5.6% from the year-ago quarter. related investment news The consumer …
Sopa Pictures | Light Rocket | Getty Images shares of Modern fell on Monday as Wall Street munched over new trial results on the personalized cancer vaccine it is developing note. Merck shares were essentially flat. The experimental mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, reduces the risk of skin cancer-melanoma recurrence by …
Continue reading “Moderna shares fall regardless of promising most cancers vaccine knowledge”
A US district judge in Washington state said Thursday access to the abortion pill mifepristone was unaffected by a federal appeals court ruling that imposed restrictions on the drug this week. Judge Thomas Rice of the state’s US Eastern District last Friday ordered the Food and Drug Administration to gain access to mifepristone in 17 …
Continue reading “Courtroom ruling doesn’t have an effect on 17 states”
In this photo illustration, packs of mifepristone tablets are on display at a family planning clinic in Rockville, Maryland on April 13, 2023. Anna Moneymaker | Getty Images The Biden administration and abortion pill distributor Danco Laboratories on Friday asked the Supreme Court to block an order threatening access to that drug, mifepristone, in an …
Continue reading “The DOJ is asking the Supreme Court docket to dam restrictions on mifepristone”
US suppliers of abortion pills are scrambling to make backup plans as the Supreme Court decides whether to keep restrictions on key drug mifepristone. Some personal clinics in New York, California and Kansas will offer mifepristone for now, but are preparing to offer an alternative abortion pill if a later decision essentially bans the drug. …
Continue reading “Clinics draw up backup plans as Supreme Court docket choice looms”
US Supreme Court Justice Samuel Alito on Friday temporarily blocked rulings by lower courts that imposed tighter restrictions on the abortion pill mifepristone. US Judge Matthew Kacsmaryk of the US Northern District of Texas last week suspended the Food and Drug Administration’s approval of mifepristone. The US 5th Circuit Court of Appeals blocked that part …
Continue reading “Supreme Court docket lifts restrictions on mifepristone for now”
